2023-04-012024-03-312024-03-31false12694025MY ORTHODONTIST LTD2024-12-20falseiso4217:GBPxbrli:pure126940252023-04-01126940252024-03-31126940252023-04-012024-03-31126940252022-04-01126940252023-03-31126940252022-04-012023-03-3112694025bus:SmallEntities2023-04-012024-03-3112694025bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3112694025bus:FullAccounts2023-04-012024-03-3112694025bus:PrivateLimitedCompanyLtd2023-04-012024-03-3112694025core:WithinOneYear2024-03-3112694025core:AfterOneYear2024-03-3112694025core:WithinOneYear2023-03-3112694025core:AfterOneYear2023-03-3112694025core:ShareCapital2024-03-3112694025core:SharePremium2024-03-3112694025core:RevaluationReserve2024-03-3112694025core:OtherReservesSubtotal2024-03-3112694025core:RetainedEarningsAccumulatedLosses2024-03-3112694025core:ShareCapital2023-03-3112694025core:SharePremium2023-03-3112694025core:RevaluationReserve2023-03-3112694025core:OtherReservesSubtotal2023-03-3112694025core:RetainedEarningsAccumulatedLosses2023-03-3112694025core:LandBuildings2024-03-3112694025core:PlantMachinery2024-03-3112694025core:Vehicles2024-03-3112694025core:FurnitureFittings2024-03-3112694025core:OfficeEquipment2024-03-3112694025core:NetGoodwill2024-03-3112694025core:IntangibleAssetsOtherThanGoodwill2024-03-3112694025core:ListedExchangeTraded2024-03-3112694025core:UnlistedNon-exchangeTraded2024-03-3112694025core:LandBuildings2023-03-3112694025core:PlantMachinery2023-03-3112694025core:Vehicles2023-03-3112694025core:FurnitureFittings2023-03-3112694025core:OfficeEquipment2023-03-3112694025core:NetGoodwill2023-03-3112694025core:IntangibleAssetsOtherThanGoodwill2023-03-3112694025core:ListedExchangeTraded2023-03-3112694025core:UnlistedNon-exchangeTraded2023-03-3112694025core:LandBuildings2023-04-012024-03-3112694025core:PlantMachinery2023-04-012024-03-3112694025core:Vehicles2023-04-012024-03-3112694025core:FurnitureFittings2023-04-012024-03-3112694025core:OfficeEquipment2023-04-012024-03-3112694025core:NetGoodwill2023-04-012024-03-3112694025core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112694025core:ListedExchangeTraded2023-04-012024-03-3112694025core:UnlistedNon-exchangeTraded2023-04-012024-03-3112694025core:MoreThanFiveYears2023-04-012024-03-3112694025core:Non-currentFinancialInstruments2024-03-3112694025core:Non-currentFinancialInstruments2023-03-3112694025dpl:CostSales2023-04-012024-03-3112694025dpl:DistributionCosts2023-04-012024-03-3112694025core:LandBuildings2023-04-012024-03-3112694025core:PlantMachinery2023-04-012024-03-3112694025core:Vehicles2023-04-012024-03-3112694025core:FurnitureFittings2023-04-012024-03-3112694025core:OfficeEquipment2023-04-012024-03-3112694025dpl:AdministrativeExpenses2023-04-012024-03-3112694025core:NetGoodwill2023-04-012024-03-3112694025core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112694025dpl:GroupUndertakings2023-04-012024-03-3112694025dpl:ParticipatingInterests2023-04-012024-03-3112694025dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3112694025core:ListedExchangeTraded2023-04-012024-03-3112694025dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3112694025core:UnlistedNon-exchangeTraded2023-04-012024-03-3112694025dpl:CostSales2022-04-012023-03-3112694025dpl:DistributionCosts2022-04-012023-03-3112694025core:LandBuildings2022-04-012023-03-3112694025core:PlantMachinery2022-04-012023-03-3112694025core:Vehicles2022-04-012023-03-3112694025core:FurnitureFittings2022-04-012023-03-3112694025core:OfficeEquipment2022-04-012023-03-3112694025dpl:AdministrativeExpenses2022-04-012023-03-3112694025core:NetGoodwill2022-04-012023-03-3112694025core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3112694025dpl:GroupUndertakings2022-04-012023-03-3112694025dpl:ParticipatingInterests2022-04-012023-03-3112694025dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3112694025core:ListedExchangeTraded2022-04-012023-03-3112694025dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3112694025core:UnlistedNon-exchangeTraded2022-04-012023-03-3112694025core:NetGoodwill2024-03-3112694025core:IntangibleAssetsOtherThanGoodwill2024-03-3112694025core:LandBuildings2024-03-3112694025core:PlantMachinery2024-03-3112694025core:Vehicles2024-03-3112694025core:FurnitureFittings2024-03-3112694025core:OfficeEquipment2024-03-3112694025core:AfterOneYear2024-03-3112694025core:WithinOneYear2024-03-3112694025core:ListedExchangeTraded2024-03-3112694025core:UnlistedNon-exchangeTraded2024-03-3112694025core:ShareCapital2024-03-3112694025core:SharePremium2024-03-3112694025core:RevaluationReserve2024-03-3112694025core:OtherReservesSubtotal2024-03-3112694025core:RetainedEarningsAccumulatedLosses2024-03-3112694025core:NetGoodwill2023-03-3112694025core:IntangibleAssetsOtherThanGoodwill2023-03-3112694025core:LandBuildings2023-03-3112694025core:PlantMachinery2023-03-3112694025core:Vehicles2023-03-3112694025core:FurnitureFittings2023-03-3112694025core:OfficeEquipment2023-03-3112694025core:AfterOneYear2023-03-3112694025core:WithinOneYear2023-03-3112694025core:ListedExchangeTraded2023-03-3112694025core:UnlistedNon-exchangeTraded2023-03-3112694025core:ShareCapital2023-03-3112694025core:SharePremium2023-03-3112694025core:RevaluationReserve2023-03-3112694025core:OtherReservesSubtotal2023-03-3112694025core:RetainedEarningsAccumulatedLosses2023-03-3112694025core:NetGoodwill2022-04-0112694025core:IntangibleAssetsOtherThanGoodwill2022-04-0112694025core:LandBuildings2022-04-0112694025core:PlantMachinery2022-04-0112694025core:Vehicles2022-04-0112694025core:FurnitureFittings2022-04-0112694025core:OfficeEquipment2022-04-0112694025core:AfterOneYear2022-04-0112694025core:WithinOneYear2022-04-0112694025core:ListedExchangeTraded2022-04-0112694025core:UnlistedNon-exchangeTraded2022-04-0112694025core:ShareCapital2022-04-0112694025core:SharePremium2022-04-0112694025core:RevaluationReserve2022-04-0112694025core:OtherReservesSubtotal2022-04-0112694025core:RetainedEarningsAccumulatedLosses2022-04-0112694025core:AfterOneYear2023-04-012024-03-3112694025core:WithinOneYear2023-04-012024-03-3112694025core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3112694025core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3112694025core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3112694025core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3112694025core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3112694025core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3112694025core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3112694025core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3112694025core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3112694025core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3112694025core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3112694025core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3112694025core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3112694025core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3112694025core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3112694025core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3112694025core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3112694025core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3112694025core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3112694025core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3112694025core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3112694025core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3112694025core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3112694025core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3112694025core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3112694025core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3112694025core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3112694025bus:Director12023-04-012024-03-3112694025bus:Director22023-04-012024-03-31

MY ORTHODONTIST LTD

Registered Number
12694025
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

MY ORTHODONTIST LTD
Company Information
for the year from 1 April 2023 to 31 March 2024

Directors

ELASSAR, Alyaa
MANSOUR, Eslam Essam Mohammed, Dr

Registered Address

19-21 Eastern Road
Romford
RM1 3NH

Registered Number

12694025 (England and Wales)
MY ORTHODONTIST LTD
Statement of Financial Position
31 March 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets38,4402,199
Tangible assets42,0952,793
10,5354,992
Current assets
Debtors-6,285
Cash at bank and on hand6061,320
6067,605
Creditors amounts falling due within one year5(32,654)(11,363)
Net current assets (liabilities)(32,048)(3,758)
Total assets less current liabilities(21,513)1,234
Net assets(21,513)1,234
Capital and reserves
Called up share capital22
Profit and loss account(21,515)1,232
Shareholders' funds(21,513)1,234
The financial statements were approved and authorised for issue by the Board of Directors on 20 December 2024, and are signed on its behalf by:
MANSOUR, Eslam Essam Mohammed, Dr
Director
Registered Company No. 12694025
MY ORTHODONTIST LTD
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. Due to the fact that the company has not traded consistently throughout the year, the directors have introduced larger than usual capital into the company to allow the company to pay it's trade creditors. Going forward the company will resume normal trade and on this basis, the directors have prepared these financial statements on a going concern basis.
Revenue from sale of goods
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
2.Average number of employees

20242023
Average number of employees during the year22
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 April 233,3763,376
Additions9,0549,054
At 31 March 2412,43012,430
Amortisation and impairment
At 01 April 231,1771,177
Charge for year2,8132,813
At 31 March 243,9903,990
Net book value
At 31 March 248,4408,440
At 31 March 232,1992,199
4.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 01 April 239704,1355,105
At 31 March 249704,1355,105
Depreciation and impairment
At 01 April 234591,8532,312
Charge for year127571698
At 31 March 245862,4243,010
Net book value
At 31 March 243841,7112,095
At 31 March 235112,2822,793
5.Creditors: amounts due within one year

2024

2023

££
Amounts owed to related parties31,120-
Taxation and social security-9,874
Accrued liabilities and deferred income1,5341,489
Total32,65411,363
6.Related party transactions
At the year end the Company owed the Directors £31,119.93 (2023: -£5,121.97). This amount is repayable upon demand. Interest has been accrued in line with the Bank of England base rate.